Literature DB >> 16373583

C-phycocyanin protects against ischemia-reperfusion injury of heart through involvement of p38 MAPK and ERK signaling.

Mahmood Khan1, Saradhadevi Varadharaj, Latha P Ganesan, Jagdish C Shobha, Madireddi U Naidu, Narasimham L Parinandi, Susheela Tridandapani, Vijay Kumar Kutala, Periannan Kuppusamy.   

Abstract

We previously showed that C-phycocyanin (PC), an antioxidant biliprotein pigment of Spirulina platensis (a blue-green alga), effectively inhibited doxorubicin-induced oxidative stress and apoptosis in cardiomyocytes. Here we investigated the cardioprotective effect of PC against ischemia-reperfusion (I/R)-induced myocardial injury in an isolated perfused Langendorff heart model. Rat hearts were subjected to 30 min of global ischemia at 37 degrees C followed by 45 min of reperfusion. Hearts were perfused with PC (10 microM) or Spirulina preparation (SP, 50 mg/l) for 15 min before the onset of ischemia and throughout reperfusion. After 45 min of reperfusion, untreated (control) hearts showed a significant decrease in recovery of coronary flow (44%), left ventricular developed pressure (21%), and rate-pressure product (24%), an increase in release of lactate dehydrogenase and creatine kinase in coronary effluent, significant myocardial infarction (44% of risk area), and TdT-mediated dUTP nick end label-positive apoptotic cells compared with the preischemic state. PC or SP significantly enhanced recovery of heart function and decreased infarct size, attenuated lactate dehydrogenase and creatine kinase release, and suppressed I/R-induced free radical generation. PC reversed I/R-induced activation of p38 MAPK, Bax, and caspase-3, suppression of Bcl-2, and increase in TdT-mediated dUTP nick end label-positive apoptotic cells. However, I/R also induced activation of ERK1/2, which was enhanced by PC treatment. Overall, these results for the first time showed that PC attenuated I/R-induced cardiac dysfunction through its antioxidant and antiapoptotic actions and modulation of p38 MAPK and ERK1/2.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16373583     DOI: 10.1152/ajpheart.01072.2005

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  30 in total

1.  Pharmacokinetics and safety of a single dose of the novel necrosis inhibitor LC28-0126 in healthy male subjects.

Authors:  Seokuee Kim; Hyewon Chung; SeungHwan Lee; Sang-Heon Cho; Hyun-Jai Cho; Soon Ha Kim; In-Jin Jang; Kyung-Sang Yu
Journal:  Br J Clin Pharmacol       Date:  2017-01-25       Impact factor: 4.335

Review 2.  Role of p38 inhibition in cardiac ischemia/reperfusion injury.

Authors:  Sarawut Kumphune; Siriporn Chattipakorn; Nipon Chattipakorn
Journal:  Eur J Clin Pharmacol       Date:  2011-12-29       Impact factor: 2.953

Review 3.  Hypolipidemic, antioxidant, and antiinflammatory activities of microalgae Spirulina.

Authors:  Ruitang Deng; Te-Jin Chow
Journal:  Cardiovasc Ther       Date:  2010-08       Impact factor: 3.023

4.  Spirulina diet to lactating mothers protects the antioxidant system and reduces inflammation in post-natal brain after systemic inflammation.

Authors:  Jaspal Patil; Ashok Matte; Carina Mallard; Mats Sandberg
Journal:  Nutr Neurosci       Date:  2016-08-29       Impact factor: 4.994

5.  Sinomenine protects mice against ischemia reperfusion induced renal injury by attenuating inflammatory response and tubular cell apoptosis.

Authors:  Zhiqing Zhao; Rui Guan; Shaohua Song; Mingjian Zhang; Fang Liu; Meng Guo; Wenyuan Guo; Qilin Yu; Luding Zhang; Quanxing Wang
Journal:  Int J Clin Exp Pathol       Date:  2013-08-15

6.  Sulfaphenazole protects heart against ischemia-reperfusion injury and cardiac dysfunction by overexpression of iNOS, leading to enhancement of nitric oxide bioavailability and tissue oxygenation.

Authors:  Mahmood Khan; Iyyapu K Mohan; Vijay K Kutala; Sainath R Kotha; Narasimham L Parinandi; Robert L Hamlin; Periannan Kuppusamy
Journal:  Antioxid Redox Signal       Date:  2009-04       Impact factor: 8.401

Review 7.  Lessons from the heart and ischemic limbs: midkine as anti-inflammatory mediator for kidney diseases?

Authors:  Delia Lidia Şalaru; Peter R Mertens
Journal:  Int Urol Nephrol       Date:  2012-12-04       Impact factor: 2.370

8.  Cardioprotection by HO-4038, a novel verapamil derivative, targeted against ischemia and reperfusion-mediated acute myocardial infarction.

Authors:  Iyyapu K Mohan; Mahmood Khan; Sheik Wisel; Karuppaiyah Selvendiran; Arun Sridhar; Cynthia A Carnes; Balazs Bognar; Tamás Kálai; Kálmán Hideg; Periannan Kuppusamy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-31       Impact factor: 4.733

9.  All-trans retinoic acid protects against doxorubicin-induced cardiotoxicity by activating the ERK2 signalling pathway.

Authors:  Liang Yang; Cheng Luo; Cong Chen; Xun Wang; Wen Shi; Jiankang Liu
Journal:  Br J Pharmacol       Date:  2015-12-19       Impact factor: 8.739

10.  Trimetazidine, administered at the onset of reperfusion, ameliorates myocardial dysfunction and injury by activation of p38 mitogen-activated protein kinase and Akt signaling.

Authors:  Mahmood Khan; Sarath Meduru; Mahmoud Mostafa; Saniya Khan; Kàlmàn Hideg; Periannan Kuppusamy
Journal:  J Pharmacol Exp Ther       Date:  2010-02-18       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.